✦ LIBER ✦

Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans

✍ Scribed by Oestreich, Julie H.; Best, Lyle G.; Dobesh, Paul P.

Book ID: 122676449
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 347 KB
Volume: 167
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-248: Prasugrel and Clopidogrel in Chi

AS-248: Prasugrel and Clopidogrel in Chinese CYP2C19 Allelic Variants following Maintenance Doses

✍ Sandra Kirkwood; Kathy McCorkle; Joseph Walker; David Small; Nagy Farid; Mei Ten 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The common gene variants of CYP2C19 affe

The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects

✍ K. UMEMURA; T. FURUTA; K. KONDO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Common polymorphisms of CYP2C19 and CYP2

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

✍ J. T. BRANDT; S. L. CLOSE; S. J. ITURRIA; C. D. PAYNE; N. A. FARID; C. S. ERNEST 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Pharmacodynamic effect of clopidogrel th

Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study

✍ Y.-H. JEONG; Y. PARK; W. C. MUSE; T. J. KWON; J.-S. KOH; S.-J. HWANG; C. H. KWAK 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The Effect of CYP2C19 Polymorphism on th

The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance

✍ Kim, KA; Park, PW; Hong, SJ; Park, J-Y 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 223 KB

CYP2C19 But Not PON1 Genetic Variants In

CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post-Myocardial Infarction Patients

✍ Hulot, J.-S.; Collet, J.-P.; Cayla, G.; Silvain, J.; Allanic, F.; Bellemain-Appa 📂 Article 📅 2011 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 497 KB